Research Peptides
RESEARCH USE ONLY
Research Peptides
RESEARCH USE ONLY
| Ingredients | Adipotide (FTPP) — prohibitin-targeting peptidomimetic, CKGGRAKDC-GG-D(KLAKLAK)2 |
|---|---|
| Storage | Store refrigerated at 2–8°C; avoid freezing and light exposure |
| Shelf life | 24 months |
| SKU | Content - Spec | Pack | Price | Stock |
|---|---|---|---|---|
| AP2 | 2mg | 10 vials | $88.00 | In stock |
| AP5 | 5mg | 10 vials | $190.00 | In stock |
Research reagents are for laboratory and in-vitro research only. Not for human use.
Research reagents are not supplied as medicines and must not be used for diagnosis, treatment, prevention, clinical procedures or self-medication. Product information must not be used as administration or dosing guidance.
For accessories and consumables, follow their own specifications and documented intended use.
Adipotide (also known as FTPP) is an experimental synthetic peptide designed to selectively target and destroy blood vessels that supply white adipose (fat) tissue. It binds to prohibitin on the surface of fat tissue vasculature, causing apoptosis of these blood vessels, which leads to fat cell death and rapid reduction in body fat. It demonstrated significant fat loss in animal studies, but it has never been approved for human use due to safety issues, particularly potential kidney toxicity.
Promotes adipocyte apoptosis; reduces localized and systemic fat; improves body fat distribution; may increase metabolic rate; supports weight loss
Typically administered subcutaneously, dosage adjusted on an individual basis (common starting dose 1–2 mg per day); treatment cycles recommended not to exceed 4 weeks; adequate water intake required
Individuals seeking to reduce stubborn fat; those with localized fat accumulation; individuals above target weight without a history of severe renal disease